Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Routinely Deferred Versus Early Invasive Strategy in Chinese Patients of 75 Years or Older With Non-ST-elevation Myocardial Infarction - a Multicenter, Open-label, Randomized Controlled Clinical Trial.

NCT02900001 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences, Fuwai Hospital as lead sponsor.

NCT NCT02900001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02900001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Routinely Deferred Versus Early Invasive Strategy in Chinese Patients of 75 Years or Older With Non-ST-elevation Myocardial Infarction - a Multicenter, Open-label, Randomized Controlled Clinical Trial.
Lead sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2016
Completion date
October 30, 2019
Enrollment
696 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-st elevation myocardial infarction